Haemostasis Unit, Antwerp University Hospital, Edegem, Belgium.
Haemostasis Research Unit, University of Antwerp, Antwerp, Belgium.
Thromb Haemost. 2019 Apr;119(4):594-605. doi: 10.1055/s-0039-1678528. Epub 2019 Feb 5.
von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative (type 1 and 3) or qualitative (type 2) defect of von Willebrand factor (VWF). The heterogeneity of laboratory phenotyping makes diagnosing difficult.
A cross-sectional, family-based VWD study in a collaboration between University Hospital Brno (Czech Republic) and Antwerp University Hospital (Belgium) to improve the understanding of laboratory phenotype/genotype correlation.
A total of 205 patients with suspected VWD were identified from historical records. Complete laboratory analysis was established using all available VWD assays including VWF multimers and genetic analysis.
Based on the current International Society of Thrombosis and Haemostasis (ISTH) - Scientific and Standardization Committee VWD classification and type 2A sub-division into 2A/IIA, IID, IIC and IIE, the majority was characterized as a type 1 VWD, followed by type 2. Proposed laboratory phenotypes were confirmed by their multimeric pattern within 98% of this cohort. All type 2, 3 and 75% of type 1 VWD patients were confirmed by underlying causative mutations. Forty-six different causal mutations (117 not previously described in the literature) could be identified. Fifty per cent of all cases was represented by eight individual mutations, mainly p.Pro812ArgfsX31. Thirteen patients had a large heterozygous gene alteration.
Although an extensive panel of tests was used, VWD classification and (sub)typing remains difficult and fluid. This study provides a cross-sectional overview of the VWD population in the Czech Republic and provides important data to the ISTH/European Association for Haemophilia and Allied Disorders VWD mutation database in linking causal mutations with unique VWD (sub)types. It also identifies new, as not previously described in the literature, causal mutations.
血管性血友病(VWD)是一种遗传性出血性疾病,由血管性血友病因子(VWF)的数量(1 型和 3 型)或质量(2 型)缺陷引起。实验室表型的异质性使得诊断变得困难。
在布尔诺大学医院(捷克共和国)和安特卫普大学医院(比利时)之间的一项横断面、基于家庭的 VWD 研究,旨在提高对实验室表型/基因型相关性的理解。
从历史记录中确定了 205 名疑似 VWD 的患者。使用所有可用的 VWD 检测方法(包括 VWF 多聚体和遗传分析)建立了完整的实验室分析。
根据当前国际血栓形成和止血学会(ISTH)-科学和标准化委员会 VWD 分类和 2A 亚型分为 2A/IIA、IID、IIC 和 IIE,大多数患者表现为 1 型 VWD,其次是 2 型。通过该队列的 98%的多聚体模式证实了所提出的实验室表型。所有 2 型、3 型和 75%的 1 型 VWD 患者均通过潜在的致病突变得到证实。可以识别出 46 种不同的致病突变(117 种以前未在文献中描述过)。所有病例中有 50%是由 8 种个体突变引起的,主要是 p.Pro812ArgfsX31。13 名患者有大的杂合基因改变。
尽管使用了广泛的检测面板,但 VWD 分类和(亚型)仍然困难且不稳定。本研究提供了捷克共和国 VWD 人群的横断面概述,并为 ISTH/欧洲血友病和相关疾病协会 VWD 突变数据库提供了重要数据,将致病突变与独特的 VWD(亚型)联系起来。它还确定了以前未在文献中描述过的新的致病突变。